BioMed Research International

BioMed Research International / 2018 / Article

Review Article | Open Access

Volume 2018 |Article ID 7625078 |

Xiao Zhai, Jian Zhao, Yiran Wang, Xianzhao Wei, Gengwu Li, Yilin Yang, Ziqiang Chen, Yushu Bai, Qijin Wang, Xiao Chen, Ming Li, "Bibliometric Analysis of Global Scientific Research on lncRNA: A Swiftly Expanding Trend", BioMed Research International, vol. 2018, Article ID 7625078, 8 pages, 2018.

Bibliometric Analysis of Global Scientific Research on lncRNA: A Swiftly Expanding Trend

Academic Editor: Paul Harrison
Received20 Jan 2018
Accepted05 Apr 2018
Published27 May 2018


To investigate trends in long-noncoding (lnc) RNA research systematically, we compared the contribution of publications among different regions, institutions, and authors. Publications on lncRNA were retrieved from Web of Science (WoS) from 1975 to 2017. A total of 3879 papers were identified, and together they were cited 62967 times. The literature on lncRNA had been continuously growing since 2006, and the expansion might continue at a rapid pace until around 2021. China contributed the greatest proportion (63.47%) of lncRNA publications, and the USA ranked second in the number of publications (944 articles), while it had the highest citation frequency (43168 times) and H-index (97). The journal Oncotarget has the greatest number of publications on lncRNA research, with 305 papers. The keywords could be stratified into two clusters: cluster 1 (application) and cluster 2 (characteristics). Correspondingly, the “TNM stage,” “epithelial mesenchymal transition (EMT),” “cell apoptosis,” and “overall survival” are research hotspots since 2015. Thus, research on lncRNA showed a swiftly expanding trend, with China making the largest contribution. The focus on lncRNA is gradually shifting from “characteristics” to “application.”

1. Introduction

With the technological innovation of RNA sequencing and computational prediction, the past decade has seen a rapid increase in the study of long-noncoding RNAs (lncRNAs). It is estimated that at least 90% of RNAs transcribed by the human genome are lncRNAs [1], and several lncRNA databases have been set up, such as lncRNAdb, NRED, lncRNA Disease, and NONCODE. For example, the NONCODE database ( lists 233,696 lncRNA transcripts and 144,134 lncRNA genes. lncRNA was previously considered as “junk gene” or transcriptional “noise” [2]; however, it is reported recently that lncRNAs might be associated with many diseases, and the number of lncRNAs with validated functions is growing exponentially. The lncRNA database ( currently lists a conservative 299 functional lncRNA genes.

Several studies have reported that lncRNAs are involved in a cluster of biochemical mechanisms including regulation of gene transcription [3] and methylation [4]. In addition, lncRNAs were reported to play an important role in human diseases such as autism spectrum disorders [5] and thoracic and abdominal aortic aneurysm [6].

Since functional analyses of these lncRNAs are generally more difficult than for coding genes, the majority of functional lncRNAs are still unknown, and no estimation or summary of the relevant scientific output has been demonstrated yet. Based on published books or journal articles, bibliometrics is often employed to assess the tendency of research activity over time, and bibliometric analysis evaluates the literature both quantitatively and qualitatively [7]. Therefore, this kind of statistical analysis can provide bibliographical information on a specific field, issue, institute, or region. Furthermore, this kind of information can assist the government in establishing guidelines, medical consensus, and funding-orientation guidance. Till now, bibliometric analyses have been performed to investigate medical research trends such as gastroenterology [8] and cancer [9].

The proposal of this study is to assess the publication pattern of lncRNA research around the world based on Web of Science (WoS) from 1975 (since WoS includes papers from 1975). This study systematically assessed the publication distribution, stratified by geography, institution, funding agencies, journals, and more. We also assessed the frequency of keywords and then employed bibliometric-mapping tools to demonstrate developments on lncRNAs. Results were analyzed to further understand the structure of this field and to anticipate developments on lncRNA research. Furthermore, this study can provide information for funding agencies to establish related guidelines on lncRNA research.

2. Materials and Methods

2.1. Sources of the Data and Search Strategy

The data in this article were based on the Science Citation Index-Expanded (SCI-E) of the Web of Science (WoS) from 1975 to 2017, since WoS included papers from 1975. A comprehensive online search was performed on a single day, July 1, 2017, to avoid daily updating bias since the database is still open.

The search key words were referred to MESH terms from PubMed and then were used as follows: TI = ( AND long) OR TI = OR TI= OR TI = (linc AND ) OR TI = ( AND long AND (noncoding OR nontranslated OR nontranslated OR noncoding OR nonprotein-coding OR nonprotein coding OR untranslated)) AND Language = English. Regarding manuscript types, only peer-reviewed articles and reviews were included.

Ethical approval was not necessary, since the data were downloaded from the public databases and did not involve any interactions with human or animal subjects.

2.2. Data Collection

The txt data download from WoS was imported into Microsoft Excel 2013, GraphPad Prism 5, and VOSviewer. The distribution characteristics such as country, institution, journals, and funding agency were analyzed by WoS and recorded by two authors (Xiao Zhai and Jian Zhao). Bibliometric indicators were extracted from the data, including publication number, citation frequency, and H-index [10, 11]. The data were analyzed both quantitatively and qualitatively.

To adjust for economic condition and population size, statistics on gross domestic product (GDP) and population sizes from the Word Bank and the Central Intelligence Agency for the most recent report were used in the study.

H-index is calculated as a measure of scientific research impact that reflects both the number of publications and the number of citations per publication: a scholar has published h papers, each of which has been cited in other papers at least h times [12].

2.3. Statistical Methods

The time trend of the publications was analyzed by fitting mathematic models with GraphPad Prism 5 (GraphPad Software Inc., CA, USA). The logistic growth model, , was used to model the cumulative volume of documentation due to its good fitness and ability to predict future trends in the literature [13, 14]. Symbol represents the year, and is the cumulative volume of paper by the year. The time point when the publication growth rate moved from positive to negative is called the inflection point of the logistic growth curve, which is generated by the formula: ''”[14].

VOSviewer (Leiden University, Leiden, Netherlands) was used to analyze the relations among highly cited references and productive authors. It is commonly used for mapping and clustering of cocitation network analysis. It also clusters citation terms and portrays the key words by color. The density of occurrence of information is portrayed by the size of the circle [15].

3. Results

3.1. Countries Contributing to Global Publications

Initially, 4932 papers were retrieved, dating back to 1975. After an exclusion process (Figure 1), 3879 studies were selected for statistical analyses. Figure 2(a) shows that lncRNAs were continuously reported since 2006. Model fitting curves () in Figure 2(b) show a significant correlation between the year and the cumulative number of lncRNA publications. The global inflection point (the time point when the publication growth rate will move from positive to negative) might be the year 2021.

In terms of the most productive countries, China accounted for the highest proportion of published research (2462 papers, 63.47%), followed by the USA (944 papers, 24.34%), and Germany (134 papers, 3.4%). Adjusted by gross domestic product (GDP), China ranked first, with 115.75 articles per trillion GDP. Adjusted by population, Australia came to the fore with 4.52 articles per million population (Table 1).

CountryN%N per million populationN per trillion GDPTotal citationsh-index


3.2. Citation And H-Index Analysis

According to the analysis of the WoS database, all articles related to lncRNA had been cited a total of 90287 times, an average of 33.8 times per paper. Specifically, the top 100 lncRNA studies (with the highest citation frequency) accounted for 36033 citations (39.91% of 90287) (Supplemental Table 1). In terms of countries, the USA has the most citations (43168) and the highest H-index (97). China ranked second with 30283 citations and an H-index of 76 (Table 1).

3.3. Distribution of Institutes Focusing on lncRNA

Nanjing Med University, China, had the greatest number of publications with a total of 272 papers, accounting for 1.94% of total published literature in the field, followed by Shanghai Jiao Tong University, China (156 publications), and Chinese Academy of Sciences, China (134 publications). Among the top 10 productive institutions, nine of them were Chinese institutes, and the other one was an American institute (Harvard University), ranking ninth (Figure 2(c)).

3.4. Distribution of Published Journals and Funding Agencies Focusing on lncRNA

The journal Oncotarget has the greatest number of publications on lncRNA research with 305 papers, followed by Tumor Biol (143 papers) and Sci Rep (142 papers) (Figure 2(d)). In total, the top 10 journals published 1106 articles, which accounted for 28.51% of all publications in this field.

The top 10 funding bodies are shown in Table 2. A total of 1280 studies (33.00%) were supported by National Natural Science Foundation of China (NCSF). National Institutes of Health (NIH) ranked second (290, 7.48%). Eight funding agencies from China are shown in the list. In addition, NIH invested in 457 projects with a total funding of $157,041,190 (, and NCSF invested in 915 projects with a total funding of 377,339,000RMB ($58,052,150) (

Funding AgencyN%

National Natural Science Foundation of China128033.00%
National Institutes of Health (NIH)2907.48%
China Postdoctoral Science Foundation641.65%
Fundamental Research Funds for the Central Universities571.47%
National Basic Research Program of China551.42%
Natural Science Foundation of Jiangsu Province551.42%
National High Technology Research and Development Program of China 863 Program360.93%
Priority Academic Program Development of Jiangsu Higher Education Institutions360.93%
European Research Council320.82%
Zhejiang Provincial Natural Science Foundation of China280.72%

3.5. Characteristics of Top 10 lncRNA Articles Cited Most Frequently

In total, the top 10 articles contributed 11386 citations, accounting for 12.61% of citations related to lncRNAs (Table 3). The research by Gupta et al. [16] published in 2010 was the most cited (1821 times) paper. Among the 10 most cited articles, two were published in Cell [3, 17], two in Nature [16, 18], one in Nature Reviews Genetics [19], one in Science [20], one in Genome Research [21], one in Annual Review of Biochemistry [22], one in Molecular Cell [23], and one in Genes & Development [24] (Table 3).

TitleFirst authorJournalImpact factorYearCitationsCitation frequency per yearMain Conclusion

Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasisGupta, RajnishNature40.1420101821227.62The lincRNA termed HOTAIR is increased in expression in primary breast tumours and metastases, and HOTAIR expression level in is a powerful predictor of eventual metastasis and death.

Long non-coding RNAs: insights into functionsMercer, TimNature Reviews Genetics40.2820091565173.89In this review, they focus on the rapidly advancing field of long ncRNAs, describing their conservation, their organization in the genome, their roles in gene regulation and their medical implications.

Evolution and Functions of Long Noncoding RNAsPonting, ChrisCell30.4120091286142.89They reviewed the evolution of lncRNAs and their roles in transcriptional regulation, epigenetic gene regulation, and disease.

Long Noncoding RNA as Modular Scaffold of Histone Modification ComplexesTsai, Miao-ChihScience37.2020101230153.75LincRNAs may serve as scaffolds by providing binding surfaces to assemble select histone modification enzymes, thereby specifying the pattern of histone modifications on target genes.

The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expressionDerrien, ThomasGenome Research11.9220121208201.33They presented and analyzed the human lncRNA annotation, produced by the GENCODE consortium within the framework of the ENCODE project and comprising 9277 manually annotated genes producing 14,880 transcripts.

Genome Regulation by Long Noncoding RNAsRinn, JohnAnnual Review of Biochemistry19.9420121007167.83LncRNAs can function as modular scaffolds to specify higher-order organization in RNP complexes and in chromatin states.

Molecular Mechanisms of Long Noncoding RNAsWang, KevinMolecular Cell14.712011912130.29They discussed the emerging archetypes of molecular functions that lncRNAs execute-as signals, decoys, guides, and scaffolds.

lincRNAs act in the circuitry controlling pluripotency and differentiationGuttman, MitchellNature40.142011818116.86They performed loss-of-function studies on most lincRNAs expressed in mouse embryonic stem (ES) cells, and found that knockdown of lincRNAs has major consequences on gene expression patterns.

Long Noncoding RNAs with Enhancer-like Function in Human CellsOrom, Ulf AnderssonCell30.41201079098.75Depletion of a number of ncRNAs led to decreased expression of their neighboring protein-coding genes, including the master regulator of hematopoiesis, SCL (also called TAL1), Snai1 and Snai2.

Long noncoding RNAs: functional surprises from the RNA worldWilusz, JeremyGenes & Development9.41200974983.22LncRNAs can function via numerous paradigms and are key regulatory molecules in the cell.

3.6. Hotspots of Research on lncRNA

VOSviewer was used to analyze keywords extracted from the titles and abstracts of 3879 articles included in this study (Supplemental Table 2). As a result, 105 keywords, which appeared more than 100 times, were included and shown in the map. These could be stratified into two clusters: cluster 1 (application) and cluster 2 (characteristics) (Figure 3). High-frequency keywords in cluster 1 were “tissue” (1229 times), “patient” (1142 times), and “progression” (753 times). For the characteristics-related research in cluster 2, the top keywords are comprised of “function” (1632 times), “gene” (1468 times), and “lncRNAs” (1236 times).

In addition, VOSviewer shows different colors according to keyword’s average year of appearance, termed “average appearing year (AAY)” (Figure 3). A keyword in blue indicates that its AAY is not recent, and a keyword in red indicates a recent AAY. As a result, “Tumor Node Metastasis (TNM) stage” had the most recent AAY of 2015.98 and appeared 136 times. “Epithelial mesenchymal transition (EMT)” had a second most recent AAY of 2015.96 with 232 appearances, followed by “cell apoptosis” with an AAY of 2015.85 and 171 appearances (Supplemental Table 2).

4. Discussion

Bibliometrics and visualized mapping may quantitatively monitor research performance in science and present predictions [25]. Bibliometric study has had impact on other scientific and professional communities. In the case of antimicrobial resistance surveillance, for example, because real-time surveillance data are often unavailable and limited, scholars have used scientometrics and found that it provides a fast, reliable, and global overview of research [26]. As a result, bibliometric studies may be a meaningful reference. In this study, we used the same method as demonstrated in our previous studies [27, 28] and evaluated lncRNA studies with respect to the contributing countries, institutions, journals, and funding agencies.

4.1. Global Trends of Research on lncRNA

From 2006 to 2017, a dramatic growth in the global publication number on lncRNA research was validated. The regression growth model of the cumulative amount showed an inflection point in 2021, which means the growth of the publication scale might increase in the coming years. Moreover, there is still the possibility that the increasing trend will go on longer than that expected from the proposed model, because the application of lncRNA as diagnostic biomarkers and as therapeutic agents might arouse more attention.

In terms of country analysis, China published 2642 articles and was the leading country in terms of productivity. Considering the factors of a large Chinese population and GDP, we performed an adjustment and found that China published 115.75 articles per trillion GDP (still ranked no. 1) and 1.79 articles per million population (ranked no. 3). Moreover, we found that although the USA published only 944 articles and was in second place, its total citations and H-index were 43168 and 97, respectively, which surpassed those of the Chinese and suggested that the impact of articles published by the USA might be higher. The quality and creativity of studies from China might be industriously improved in the future.

In terms of journals, we observed that the Oncotarget published far more lncRNA research papers, with 305 articles, than other journals. It was indicated that future development within lncRNA would likely be released within Oncotarget and the aforementioned journals on the list (Figure 1D).

4.2. Research Focuses on lncRNA

The details of the top 10 cited articles are shown in Table 3, and we have listed the top 100 cited articles in Supplemental Table 1. We found that the top 100 studies (2.58% of 3879) had been cited 36033 times (39.91% of 90287), which indicated that these 100 studies might be classic and fundamental for further studies and should be read by those new to the field.

As shown in bibliometric mapping of keywords in Figure 3, it was observed that the focus on lncRNA research is gradually shifting from “characteristics” to “application” over the past 4 years. This is in accordance with the law of the development of a new discipline and translational medicine. Once the basic knowledge of the lncRNA was recognized, its application followed. For application studies, the lncRNA has the potential for diagnosis as a biomarker [29]. It was recommended that lncRNA might be a treatment target in the future. Therefore, further studies should focus on translational research.

In cluster 1 of “application,” the words “function” (1632 times, appearing on average in 2015.14) and “gene” (1468 times, appearing on average in 2015.00) were the most used. The article titled “Long Noncoding RNA HOTAIR Reprograms Chromatin State to Promote Cancer Metastasis” has been cited the most, at 1281 times in total and 227.62 times per year, since this article was published in Nature in 2010 [16]. This article proposed that the lncRNA HOTAIR was increased in expression in primary breast tumors and metastases, and the HOTAIR expression level is a powerful predictor of eventual metastasis and death.

Regarding the most recent lncRNA research hotspots, the “TNM stage” [30], “epithelial mesenchymal transition (EMT)” [31], and “cell apoptosis” [32, 33] showed up with the most recent AAY. For instance, in the category “TNM stage,” Cui, Y. et al. [30] found that, for those individuals suffering from nonsmall cell lung cancer, higher SNHG1 transcript levels indicated the advanced TNM stage and lymph node metastasis. In the category “epithelial mesenchymal transition”, Hao, Y. et al. [31] reported that for prostate cancer the increased transcripts of PlncRNA-1 induced epithelial mesenchymal transition. In the category “cell apoptosis”, Li, Z. et al. [32] proposed that in glioma cells the lncRNA MALAT1 promoted proliferation and suppressed apoptosis.

Therefore, we believe that scientific breakthroughs might be related to these hotspots in recent years. As for the prospective application of the VOSviewer map, we suggest that authors could select research topics from the map and demonstrate its importance as frontier hotspot by the map, and funding agents might be suggested to invest in these orientations.

4.3. Strengths and Limitations

This bibliometric description and mapping provided a birds-eye view of information on lncRNA-related research for readers to comprehend the history of published lncRNA articles in just a few minutes. In addition, we evaluated the research strength of countries and institutions, which scholars might refer to in order to find cooperative institutions.

During our research using the WoS database, we tried to guarantee comprehension and objectivity. However, we must consider the following limitations. Firstly, only publications written in English were included this study, which, inevitably, missed some significant studies on lncRNA published in other languages. Secondly, other databases such as Scopus or Embase were not analyzed. The WoS database of Science Citation Index Expanded (SCIE) includes publications that represent studies in the discipline, since journals included are selected via a rigorous process under the guidance of the concept of Bradford's law in bibliometrics, and WoS also provides metadata with further distribution refinement. Thirdly, there were still differences between real research conditions and the bibliometric analysis results, since some recently published papers do not have high citation frequency, as reported by Stephan et al., in Nature [34]. Lastly, the data in this study are open to expansion, with new studies being published each day, and the increasing trend of publication number might go on for longer than is expected from the proposed model.

5. Conclusions

The literature on lncRNA had been continuously growing since 2006, and expansion is expected until around 2021. China made the largest contribution in the lncRNA research, and Oncotarget published the most related articles. All publications can be divided into two clusters, “characteristics” and “application,” and the focus on lncRNA research has been gradually shifting from “characteristics” to “application.” In the relatively new “application” cluster, “TNM stage,” “epithelial mesenchymal transition (EMT),” and “cell apoptosis” may be the latest research hot spots, and related studies may be in the leading position in the lncRNA field in the near future.

Data Availability

The datasets analysed during the current study are available from the corresponding author on reasonable request.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Authors’ Contributions

Xiao Zhai, Jian Zhao, and Yiran Wang contributed equally to this work.


This study was supported by Foundation of Changhai Hospital (CH201717) and National Natural Science Foundation of China (81701199, 81601953, and 81670741).

Supplementary Materials

Supplemental Table : details of the top 100 lncRNA articles with the most citations. Supplemental Table : details of group items by cluster in VOSviewer. (Supplementary Materials)


  1. S. Djebali, C. A. Davis, A. Merkel et al. et al., “Landscape of transcription in human cells,” Nature, vol. 489, no. 7414, pp. 101–108, 2012. View at: Publisher Site | Google Scholar
  2. A. F. Palazzo and E. S. Lee, “Non-coding RNA: what is functional and what is junk?” Frontiers in Genetics, vol. 5, article 2, pp. 1–11, 2015. View at: Publisher Site | Google Scholar
  3. C. P. Ponting, P. L. Oliver, and W. Reik, “Evolution and functions of long noncoding RNAs,” Cell, vol. 136, no. 4, pp. 629–641, 2009. View at: Publisher Site | Google Scholar
  4. V. O'Leary, S. V. Ovsepian, L. G. Carrascosa et al., “PARTICLE, a triplex-forming long ncRNA, regulates locus-specific methylation in response to low-dose irradiation,” Cell Reports, vol. 11, no. 3, pp. 474–485, 2015. View at: Publisher Site | Google Scholar
  5. J. Tang, Y. Yu, and W. Yang, “Long noncoding RNA and its contribution to autism spectrum disorders,” CNS Neuroscience & Therapeutics, vol. 23, no. 8, pp. 645–656, 2017. View at: Publisher Site | Google Scholar
  6. Y. Li and L. Maegdefessel, “Non-coding RNA contribution to thoracic and abdominal aortic aneurysm disease development and progression,” Frontiers in Physiology, vol. 8, article no. 429, 2017. View at: Publisher Site | Google Scholar
  7. S. Ekinci, M. Agilli, O. Ersen, and G. H. Ekinci, “Letter to the editor regarding analysis of changing paradigms of management in 179 patients with spinal tuberculosis during a 12-year period and proposal of a new management algorithm,” World Neurosurgery, vol. 84, no. 6, p. 2072, 2015. View at: Publisher Site | Google Scholar
  8. G. Lewison, “Gastroenterology research in the United Kingdom: Funding sources and impact,” Gut, vol. 43, no. 2, pp. 288–293, 1998. View at: Publisher Site | Google Scholar
  9. R. W. Glynn, C. Scutaru, M. J. Kerin, and K. J. Sweeney, “Breast cancer research output, 1945-2008: A bibliometric and density-equalizing analysis,” Breast Cancer Research, vol. 12, no. 6, article no. R108, 2010. View at: Publisher Site | Google Scholar
  10. D. D'Arcangelo, C. Giampietri, F. Facchiano, and A. Facchiano, “BAMM: A preliminary Bibliometric Analysis on Melanoma Manuscripts,” Pigment Cell & Melanoma Research, vol. 26, no. 3, pp. 415–417, 2013. View at: Publisher Site | Google Scholar
  11. L. Bornmann and H.-D. Daniel, “The state of h index research. Is the h index the ideal way to measure research performance?” EMBO Reports, vol. 10, no. 1, pp. 2–6, 2009. View at: Publisher Site | Google Scholar
  12. J. E. Hirsch, “An index to quantify an individual's scientific research output,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 102, no. 46, pp. 16569–16572, 2005. View at: Publisher Site | Google Scholar
  13. S. C. Bagley, H. White, and B. A. Golomb, “Logistic regression in the medical literature: standards for use and reporting, with particular attention to one medical domain,” Journal of Clinical Epidemiology, vol. 54, no. 10, pp. 979–985, 2001. View at: Publisher Site | Google Scholar
  14. Z.-J. Jia, B. Hong, D.-M. Chen et al., “China's growing contribution to global intracranial aneurysm research (1991-2012): A bibliometric study,” PLoS ONE, vol. 9, no. 3, Article ID e91594, 2014. View at: Publisher Site | Google Scholar
  15. G. M. Khalil and C. A. Gotway Crawford, “A bibliometric analysis of U.S.-based research on the behavioral risk factor surveillance system,” American Journal of Preventive Medicine, vol. 48, no. 1, pp. 50–57, 2015. View at: Publisher Site | Google Scholar
  16. R. A. Gupta, N. Shah, K. C. Wang et al., “Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis,” Nature, vol. 464, no. 7291, pp. 1071–1076, 2010. View at: Publisher Site | Google Scholar
  17. U. A. Ørom, T. Derrien, M. Beringer et al., “Long noncoding RNAs with enhancer-like function in human cells,” Cell, vol. 143, no. 1, pp. 46–58, 2010. View at: Publisher Site | Google Scholar
  18. M. Guttman, J. Donaghey, B. W. Carey et al., “LincRNAs act in the circuitry controlling pluripotency and differentiation,” Nature, vol. 477, no. 7364, pp. 295–300, 2011. View at: Publisher Site | Google Scholar
  19. T. R. Mercer, M. E. Dinger, and J. S. Mattick, “Long non-coding RNAs: insights into functions,” Nature Reviews Genetics, vol. 10, no. 3, pp. 155–159, 2009. View at: Publisher Site | Google Scholar
  20. M.-C. Tsai, O. Manor, Y. Wan et al., “Long noncoding RNA as modular scaffold of histone modification complexes,” Science, vol. 329, no. 5992, pp. 689–693, 2010. View at: Publisher Site | Google Scholar
  21. T. Derrien, R. Johnson, G. Bussotti et al., “The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression,” Genome Research, vol. 22, no. 9, pp. 1775–1789, 2012. View at: Publisher Site | Google Scholar
  22. J. L. Rinn and H. Y. Chang, “Genome regulation by long noncoding RNAs,” Annual Review of Biochemistry, vol. 81, pp. 145–166, 2012. View at: Publisher Site | Google Scholar
  23. K. C. Wang and H. Y. Chang, “Molecular mechanisms of long noncoding RNAs,” Molecular Cell, vol. 43, no. 6, pp. 904–914, 2011. View at: Publisher Site | Google Scholar
  24. J. E. Wilusz, H. Sunwoo, and D. L. Spector, “Long noncoding RNAs: functional surprises from the RNA world,” Genes & Development, vol. 23, no. 13, pp. 1494–1504, 2009. View at: Publisher Site | Google Scholar
  25. R. J. W. Tijssen and J. Winnink, “Twenty-first century macro-trends in the institutional fabric of science: bibliometric monitoring and analysis,” Scientometrics, vol. 109, no. 3, pp. 2181–2194, 2016. View at: Publisher Site | Google Scholar
  26. C. Brandt, O. Makarewicz, T. Fischer et al., “The bigger picture: The history of antibiotics and antimicrobial resistance displayed by scientometric data,” International Journal of Antimicrobial Agents, vol. 44, no. 5, pp. 424–430, 2014. View at: Publisher Site | Google Scholar
  27. Y. Wang, Q. Wang, R. Zhu et al., “Trends of spinal tuberculosis research (1994-2015): A bibliometric study,” Medicine (United States), vol. 95, no. 38, Article ID e4923, 2016. View at: Publisher Site | Google Scholar
  28. W. Yiran, W. Qijin, W. Xianzhao et al., “Global scientific trends on exosome research during 2007-2016: A bibliometric analysis,” Oncotarget , vol. 8, no. 29, pp. 48460–48470, 2017. View at: Publisher Site | Google Scholar
  29. L. Guo, K. Xu, H. Yan, H. Feng, L. Chai, and G. Xu, “Expression Profile of Long Noncoding RNAs in Human Earlobe Keloids: A Microarray Analysis,” BioMed Research International, vol. 2016, Article ID 5893481, 9 pages, 2016. View at: Publisher Site | Google Scholar
  30. Y. Cui, F. Zhang, C. Zhu, L. Geng, T. Tian, and H. Liu, “Upregulated lncRNA SNHG1 contributes to progression of nonsmall cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway,” Oncotarget , vol. 8, no. 11, pp. 17785–17794, 2017. View at: Publisher Site | Google Scholar
  31. Y. Hao, X. Yang, D. Zhang, J. Luo, and R. Chen, “Long noncoding RNA LINC01186, regulated by TGF-β/SMAD3, inhibits migration and invasion through Epithelial-Mesenchymal-Transition in lung cancer,” Gene, vol. 608, pp. 1–12, 2017. View at: Publisher Site | Google Scholar
  32. Z. Li, C. Xu, B. Ding, M. Gao, X. Wei, and N. Ji, “Long non-coding RNA MALAT1 promotes proliferation and suppresses apoptosis of glioma cells through derepressing Rap1B by sponging miR-101,” Journal of Neuro-Oncology, vol. 134, no. 1, pp. 19–28, 2017. View at: Publisher Site | Google Scholar
  33. S. Liu, G. Yan, J. Zhang, and L. Yu, “Knockdown of Long Noncoding RNA (lncRNA) Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Inhibits Proliferation, Migration, and Invasion and Promoted Apoptosis By Targeting miR-124 in Retinoblastoma,” Oncology Research: Featuring Preclinical and Clinical Cancer Therapeutics, vol. 26, no. 4, pp. 581–591, 2018. View at: Publisher Site | Google Scholar
  34. P. Stephan, R. Veugelers, and J. Wang, “Reviewers are blinkered by bibliometrics,” Nature, vol. 544, no. 7651, pp. 411-412, 2017. View at: Publisher Site | Google Scholar

Copyright © 2018 Xiao Zhai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.